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Since the  identification of the  IgE antibody class  as  a  major source of reaginic 
activity (1), the mechanisms that regulate the IgE system have attracted increasing 
attention from immunologists, in view of the potential role of this antibody in allergic 
disease(s). While the low levels of IgE encountered in biological fluids have hampered 
the  development of modern  immunoassay  techniques  for the  quantitation  of this 
antibody isotype, the passive cutaneous anaphylaxis (PCA)1 bioassay (2) has provided 
a means to illustrate the basic features of IgE immunoregulation. 
Using this technique to monitor the development of IgE responses in experimental 
animals via measurement of serum antibody titers, it has been possible to show that 
the IgE system is  tightly regulated by T  lymphocytes (3,  4), which  function in an 
apparently class-specific fashion (5, 6, reviewed in 7). 
Despite the success of these studies  on T-B cell interaction in  the  IgE response, 
relatively little direct information exists on the biology of the B cells committed to 
expression of the epsilon heavy chain. These cells have been thought to be derived 
from a single lineage committed to IgE production (8, 9). However, recent studies on 
precursor  frequency suggest  that  the  major  influence  attributable  to  the  B  cells 
themselves, with regard to isotype commitment, stems from their maturational state, 
with the predominant form of regulation occurring at the T  cell level (10). Studies on 
the frequency of mature IgE immunoglobulin-secreting cells (ISC) during the course 
of primary and secondary antibody responses have not been technically feasible, and 
are clearly necessary for further elucidation of the immunoregulatory mechanisms 
that control expression of this isotype. 
This  paper  describes  a  novel  method  for enumeration  of IgE  ISC  based  upon 
enzyme-linked immunosorbent  assay  (ELISA)  methodology, which  is  used  in  the 
study below on the organ distribution and kinetics of development of IgE ISC during 
the course of the primary and secondary antibody response in the rat. The results of 
this  study  implicate  the  draining  lymph  node  as  the  major  site  of IgE  and  IgG 
synthesis during the primary response, with the spleen contributing significantly only 
to the IgM class. 
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Materials  and  Methods 
Animals and Immunizations.  Male Brown  Norway  (BN)  rats  aged  12-16  wk were used  in 
experiments that  examined primary and  secondary antibody responses.  The  animals were 
immunized intraperitoneally with 100 #g ovalbumin (OVA) plus 10 mg aluminium hydroxide 
and rechallenged (where indicated) 14 d later with the same antigen-adjuvant dose. Male WAG 
rats were used as PCA recipients, and  SPF Lou/M  animals inoculated with Nippostrongylus 
brasiliensis larvae were used in studies on the enumeration of total numbers of IgE-ISC. 
ELISA Reagents.  The specificity of Rb-anti-rat IgG (y-chain specific) (Cappel Laboratories, 
Cochranville, PA) and rabbit (Rb)-anti-rat IgM) (#-chain specific) (Nordic Immunology, The 
Netherlands) were confirmed in preliminary tests, and these reagents were used without further 
purification. Sheep (Sh)-anti-Rb IgG (a gift from Dr. G. Stewart of these laboratories) was 
repeatedly passaged through an immunoabsorbent column comprising a  40%  saturated am- 
monium  sulfate precipitate of normal  rat  serum  (NRS),  to  remove anti-rat  IgG and  IgM 
activity. Rb-anti-rat IgE  (a gift from Associate Professor K. J. Turner of these laboratories) 
raised against the IR  162  IgE myeloma was initially immunopurified using IR 331  rat IgE 
myeloma protein, and subsequently absorbed against 50 and 40% saturated ammonium sulfate 
precipitates of NRS  as  above.  Sh-anti-rat  IgE  (E-chain  specific)  (Miles  Laboratories  Inc., 
Elkhart, IN) was similarly immunopurified, followed by absorptions against glutaraldehyde- 
cross-linked NRS,  a  40%  saturated ammonium  sulfate precipitate of NRS  and  protein A- 
purified IgG from NRS. These reagents were monitored for cross-reactivity with purified IgM 
and IgG by conventional ELISA. 
The AP substrate used in the ELISA-ISC assay was 5-bromo-4-chloro-3-indolyl phosphate 
(5-BCIP) (Sigma Chemical Co., St. Louis, MO). Preparation of the substrate and its use in an 
agarose overlay are detailed elsewhere (I 1).  Conventional ELISA assays used p-nitrophenyl 
phosphate (Sigma Chemical Co.) as the AP substrate. 
Serum Antibody Determinations.  IgM and IgG-anti-OVA levels were determined by conven- 
tional ELISA, using the method of Voller et al. (12).  Serum IgE titers were measured via the 
PCA system (2). 
Heterologous Adoptive Cutaneous Anaphylaxis (HACA) Assays.  The method described in (13) was 
used, whereby single-cell suspensions of splenic and  lymph node lymphocytes were injected 
intradermally into the shaved backs of WAG rats. The diameter of blueing after a subsequent 
ehaUenge with OVA and Evans Blue was a measure of the IgE produced by the lymphoid cells 
in situ. 
Enumeration of OVA-specific ISC by the ELISA Plaque Assay.  A method recently developed in 
this laboratory for enumeration of IgM and IgG ISC was used in the present study, with some 
modification. Briefly, 24-well Nunc  tissue-culture plates were used, precoated with OVA as 
described (11).  1.0 ml of a suspension of putative ISC (104-107 cells/ml) in Dulbecco's PBS plus 
15% fetal calf serum was added to the washed wells, which were incubated for 2 h at 37°C (for 
IgG and IgM) or 4 h at 32°C (for IgE assays); these conditions were adopted after preliminary 
experiments, and represent optimal conditions for the respective isotypes. 
After the initial incubation with cells and washing, appropriate developing antisera (Rb- 
anti-rat IgM, IgG, or IgE) were added to the wells and the plates were incubated for 2 h at 37 
or 4°C overnight. Localized zones of complexed Rb-anti-rat Ig were subsequently developed 
via the application of a  Sh-anti-Rb IgG-AP conjugate, followed by the AP substrate, 5-BCIP 
in 36°C gelling agarose (11). Macroscopic blue spots or "plaques" became visible within 15-30 
rain at room temperature, and were routinely counted after 1 h. 3 M  NaOH was then added 
to the plates to stop the AP reaction if storage was desired. 
Enumeration of Total IgE Secreting Cells.  These experiments used mesenteric lymph nodes and 
spleen cells from Lou/M rats, prepared  14 d  after the subcutaneous inoculation of 2,500  N. 
brasiliensis larvae. The assay system was as detailed above, except that precoating of plates was 
performed with Sh-anti-rat IgE instead of OVA. The antiserum was applied at  1 #g/ml  in 
coating buffer on the basis of preliminary dose-response experiments. 
Results 
ELISA-Plaque  Production by IgE-ISC.  The  microscopic appearance  of IgE-ELISA 
plaques  is  shown  in  Fig.  1,  and  the  pattern  is  not  discernibly different  from  that 
produced by cells secreting other antibody isotypes. These  plaques were  developed 2180  SEDGWICK AND  HOLT  BRIEF  DEFINITIVE REPORT 
FIo.  1.  Microscopic  appearance of ELISA plaques produced by IgE ISC. Magnification, × 135. 
after initial incubation of parathymic lymph node cells from OVA-immunized rats 
on  a  plate  coated  with  OVA,  followed  immediately  by  exposure  of the  plate  to 
affinity-purified Rb-anti-rat IgE. The granular appearance of the plaques is typical; 
the  isolated small  dots  exterior to  the large plaques  are artifacts, which  appear to 
result either from the adsorption of diffused AP product onto particulate impurities 
within the gel or onto adhering cells. 
IgE Response Following  Intraperitoneal  Challenge.  The main lymphatic drainage from 
the peritoneal cavity in  the  rat  is  to  the  parathymic lymph  nodes  (14),  and  these 
appear to represent the major site of IgE synthesis during the primary response. Fig. 
2 demonstrates that by day 9 these nodes contained ~ 12,000 OVA-specific IgE-ISC; 
in contrast, 34,000 IgM and  ~ 117,000 specific IgG-ISC were observed at  this time. 
The primary IgE response was rapidly terminated after day 9, and by day  14 only 
200  IgE-ISC  were  found  in  these  lymph  nodes.  The  splenic  contribution  to  the 
primary response was restricted to the IgM isotype. Restimulation of these animals at 
day 14 failed to elicit significant changes in OVA-specific IgE or IgM-ISC numbers, 
whereas  IgG  responses  displayed  significant  boosting.  The  relative  frequencies  of 
OVA-specific cells secreting the IgE and IgG isotypes during the primary response is 
in  general agreement with  the results of a  recent clonal analysis  of the mouse IgE 
response (10). 
Serum anti-OVA PCA titers in these animals during the response mirrored figures 
for IgE ISC numbers  in  the draining node, which suggests that  these lymph nodes 
represented the major site of IgE synthesis. ISC numbers in the tissues were clearly 
dissociated from serum titers for the other isotypes, indicating that  significant IgM 
and IgG synthesis was occurring in organs that were not examined in this study. 
Specificity of IgE-ELISA Plaques.  Rat  IgE of sufficient purity for direct  blocking 
experiments was not available to us as the time of this study;  however, a  variety of 
indirect evidence attests  to the specificity of the IgE-ELISA plaques in  this system 
(see also reference 11): (a) precoating with irrelevant antigen(s) or inclusion of soluble 
OVA at the cell incubation step abrogated plaque development, and the latter was 
not  seen  in  cells  from  nonimmune  rats;  (b)  IgE  ISC  numbers  in  organs  varied 
independently of IgM and IgG during the response (Fig. 2); and (c) splenocytes from 
hyperimmune rats yielded large numbers  of IgG ISC  without  discernible IgE ISC 
(data not shown). 
A  number of experiments have also been performed with  the parallel use of the 
HACA  assay  for  IgE  ISC.  While  direct  comparisons  between  these  systems  are 
difficult, due  to  the  semiquantitative  nature  of the  HACA,  it  can  be  stated  that 
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Fro.  2.  Primary and secondary IgE response of BN rats. Animals were immunized on day 0 with 
OVA plus aluminium hydroxide, and their primary anti-OVA antibody responses were followed up 
to day 28 (----). One group was given a secondary challenge on day (  ). Stars at day 28 represent 
significant secondary responses,  comparing challenged with nonchallenged figures. 
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FIG.  3.  HACA assay for IgE ISC. Data shown represent diameters of OVA-specific HACA reaction 
elicited by the day 9 lymph node (0) or spleen (O) used in the experiments in Fig. 2, which showed 
97 and 0 IgE ISC/10  e cells,  respectively, in the ELISA plaque assay. Hatched area represents the 
range of results obtained with cells from nonimmune animals. 
by HACA. Fig. 3 illustrates the relative sensitivity of the two methods applied to cells 
from rats actively synthesizing IgE: the cells tested here were the day 9 sample from 
the lymph nodes in Fig 2.  2.5 ×  106 cells represented the minimum  requirement  for 
a  positive HACA response in this experiment, whereas the plaque assay detected  50 
IgE ISC after addition of only 5 ×  105 cells. 
IgE-ISC  in N.  brasiliensis-infested Rats.  Precoating  of plates  with  Sh-anti-rat  IgE 
before the addition of lymphocytes permits identification of IgE-secreting cells on the 
basis  of isotype.  Table  I  indicates  that  infestation  of rats with a  helminth  parasite 
differentially  stimulates  the expansion  of IgE-secreting  clones  in  mesenteric  lymph 
nodes,  but  not  in  central  lymphoid  organs  such  as  the spleen.  This  observation  is 2182  SEDGWICK  AND  HOLT  BRIEF  DEFINITIVE  REPORT 
TABLE  ] 
Total Numbers of lgE ISC in Helminth-parasitized Rats 
ISC/10  ~ lymphoid  ISC/organ 
cells  Cell yields x  106 
Animals  Mesenteric  Mesen- 
Mesenteric  teric  lymph  Spleen  Spleen 
node  lymph node  lymph 
node 
Spleen 
Controls  <5  <5  33  < 10  33  112 
Parasitized  2,652  <5  472,056  740  178  185 
Male  Lou/M  rats were inoculated subcutaneously with  2,500 third-stage Nippostrongylus  brasiliensis  larvae. Single-cell 
suspensions were assayed for total IgE ISC as detailed in Materials and Methods. Results shown are means from three 
animals. 
consistent  with  earlier  studies  using  fluorescence  techniques  (15) and  a  reverse 
hemolytic plaque assay for IgE ISC (16). 
Discussion 
The results of this study illustrate the potential usefulness of the ELISA plaque 
assay in the study of cellular aspects of IgE immunoregulation. The impact of the 
Jerne hemolytic plaque assay on progress in the general area of humoral immunity is 
a matter of record, but the lack of a suitable assay for cells secreting the IgE isotype 
has meant that many of the assumptions concerning regulation of this antibody at 
the tissue level are inferential, or at best based upon indirect evidence. It is hardly 
surprising, therefore, that issues as basic as the nature of primary sites of IgE synthesis 
still remain controversial, with opinion polarized either for (17, 18) or against (15,  19) 
a  mucosal location for cells secreting this antibody isotype. The importance of this 
issue in relation to allergy eannot be overstated, given that many of the proposed 
strategies for immunological intervention are conceptually based upon stimulating 
negative control mechanism(s) that operate at the level of the antibody-secreting cells. 
The present study, although restricted to a single mode of antigenic challenge in a 
single species, provides the first line of direct evidence relevant to this question. The 
demonstration of antigen-specific IgE synthesis in the regional lymph node draining 
the site of primary immunization, and of major clonal expansion of IgE-secreting cells 
in the mesenteric lymph nodes after infestation with a gut-dwelling helminth parasite, 
supports the view that production of this antibody isotype is not primarily a mucosal 
phenomenon. The further application of this technique to a  wider range of experi- 
mental models is required, however, before this issue can be resolved. 
It  must be  stressed,  in  conclusion, that  the  precision of this  technique depends 
absolutely upon the use of suitably purified and absorbed anti-Ig reagents. This is 
particularly the case when enumerating small numbers of IgE ISC against a  10-fold 
background of IgG ISC, as occurs during the primary immune response. 
Summary 
A  new  assay  system  is  described  for  the  enumeration  of antigen-specific  IgE 
immunoglobulin-secreting cells (ISC) based on an enzyme-linked immunoabsorbent 
assay. Using this technique to monitor the organ distribution of OVA-specific ISC 
after primary immunization of rats, ~ 12,000  specific IgE ISC were detected at the 
peak of the response in the draining lymph nodes compared with 117,000  IgG ISC; 
the splenic anti-OVA response was restricted to the IgM class. Using plates precoated SEDGWICK  AND  HOLT  BRIEF  DEFINITIVE REPORT  2183 
with anti-rat  IgE instead of antigen,  total IgE ISC were enumerated  in normal and 
helminth-parasitized  rats.  The  assay  system  detected  up  to  5  ×  105  IgE  ISC  in 
mesenteric lymph nodes from parasitized animals compared with <50 in controls. 
We gratefully acknowledge Dr. G. A. Stewart for his suggested use of the 5-BCIP substrate and 
Associate Professor K. J. Turner for providing parasite-infested animals. 
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